Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models

L. H. Porter, J. J. Zhu, N. L. Lister, S. G. Harrison, S. Keerthikumar, D. L. Goode, R. Quezada Urban, D. J. Byrne, A. Azad, I. Vela, M. S. Hofman, P. J. Neeson, P. K. Darcy, J. A. Trapani, R. A. Taylor, G. P. Risbridger

Research output: Contribution to journal › Article › Research › peer-review

32 Citations (Scopus)

1 Active
2 Finished

3 results

Active

Developing novel CAR T cell therapy approaches to treat prostate cancer
Taylor, R. (Primary Chief Investigator (PCI)), Porter, L. (Chief Investigator (CI)), Trapani, J. (Associate Investigator (AI)), Darcy, P. (Associate Investigator (AI)), Neeson, P. J. (Associate Investigator (AI)), Risbridger, G. (Associate Investigator (AI)), Risbridger, G. (Associate Investigator (AI)), Solomon, B. (Associate Investigator (AI)), Azad, A. (Associate Investigator (AI)) & Furic, L. (Associate Investigator (AI))
1/01/22 → 31/12/25
Project: Research
Finished

Targeting castrate-tolerant prostate cancer cells
Taylor, R. (Primary Chief Investigator (PCI))
Victorian Cancer Agency
24/04/16 → 23/04/20
Project: Research
NHMRC Research Fellowship
Risbridger, G. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
9/03/01 → 31/12/20
Project: Research

File